UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058427
Receipt number R000066803
Scientific Title Assessment of Voluntary Cough and Involuntary Cough Evoked by Citric Acid Inhalation
Date of disclosure of the study information 2025/07/10
Last modified on 2025/07/10 22:55:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Assessment of Voluntary Cough and Involuntary Cough Evoked by Citric Acid Inhalation

Acronym

Cough Evaluation Study

Scientific Title

Assessment of Voluntary Cough and Involuntary Cough Evoked by Citric Acid Inhalation

Scientific Title:Acronym

Cough Evaluation Study

Region

Japan


Condition

Condition

Respiratory diseases (e.g., pneumonia), laryngeal and pharyngeal diseases (e.g., vocal cord paralysis), impaired consciousness, tracheostomy tube placement and healthy adults

Classification by specialty

Rehabilitation medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We devised a method to measure cough peak flow (CPF) through the oropharynx using a peak flow meter during involuntary cough (cough reflex) induced by nasal administration of citric acid via a mesh nebulizer, and aimed to evaluate its utility.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

CPF during Involuntary and Voluntary Cough

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Adults aged 20 years or older who provided written informed consent to participate in the study based on sufficient explanation and understanding, and of their own free will or that of their family.

Key exclusion criteria

Patients with severe uncontrolled asthma

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Yohei
Middle name
Last name Otaka

Organization

Fujita Health University

Division name

Department of Rehabilitation Medicine, School of Medicine

Zip code

470-1192

Address

1-98 Dengakugakubo, Kutsukakecho,Toyoake, Aichi

TEL

0562-93-2167

Email

otaka119@mac.com


Public contact

Name of contact person

1st name Hirotaka
Middle name
Last name Matsuura

Organization

Fujita Health University

Division name

Department of Rehabilitation Medicine, School of Medicine

Zip code

454-8509

Address

1-98 Dengakugakubo, Kutsukakecho,Toyoake, Aichi

TEL

052-323-5628

Homepage URL


Email

hero850411@yahoo.co.jp


Sponsor or person

Institute

Fujita Health University

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science (JSPS)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fujita Health University

Address

1-98 Dengakugakubo, Kutsukake-cho,Toyoake, Aichi 470-1192

Tel

+81-562-93-2865

Email

f-irb@fujita-hu.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

HM24-495

Org. issuing International ID_1

Fujita Health University Medical Research Ethics Committee

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 07 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2025 Year 06 Month 05 Day

Date of IRB

2025 Year 07 Month 01 Day

Anticipated trial start date

2025 Year 07 Month 01 Day

Last follow-up date

2029 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The authors declare no conflicts of interest related to this study.


Management information

Registered date

2025 Year 07 Month 10 Day

Last modified on

2025 Year 07 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066803